Interleukin-1β induces substance P release from primary afferent neurons through the cyclooxygenase-2 system

Journal of Neurochemistry

Volumn 73, Issue 5, 1999, Pages 2206-2213

  Inoue, Atsuko ^a   Ikoma, Kozo ^a   Morioka, Norimitsu ^a   Kumagai, Kei ^a   Hashimoto, Takashi ^a   Hide, Izumi ^a   Nakata, Yoshihiro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclooxygenase 2; Dorsal root ganglion cells; Interleukin 1 receptor antagonist; Interleukin 1 ; NS 398; Substance P

Indexed keywords

CYCLOOXYGENASE 2; DEXAMETHASONE; INDOMETACIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; PROSTAGLANDIN SYNTHASE INHIBITOR; SUBSTANCE P; CYCLOOXYGENASE 2 INHIBITOR; EGTAZIC ACID; GLUCOCORTICOID; IL1RN PROTEIN, MOUSE; INTERLEUKIN 1; ISOENZYME; MESSENGER RNA; PREPROTACHYKININ; PROSTAGLANDIN SYNTHASE; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN; TACHYKININ;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; HYPERALGESIA; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SENSORY NERVE; SPINAL GANGLION; ANIMAL; CELL CULTURE; CULTURE MEDIUM; DRUG EFFECT; GENETICS; METABOLISM; SENSORY NERVE CELL; WISTAR RAT;

ANIMALIA;

ANIMALS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DEXAMETHASONE; EGTAZIC ACID; GANGLIA, SPINAL; GLUCOCORTICOIDS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; ISOENZYMES; MALE; NEURONS, AFFERENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; RNA, MESSENGER; SIALOGLYCOPROTEINS; SUBSTANCE P; TACHYKININS;

EID: 0032589741     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.02206.x     Document Type: Article

References (52)

1. Barrios-Rodiles M., and Chadee K. (1998) Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-γ in human macrophages. J. Immunol. 161, 2441-2448.
2. Beiche F., Klein T., Nusing R., Neuhuber W., and Goppelt-Struebe M. (1998) Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord. J. Neuroimmunol. 89, 26-34.
3. Bianchi M., Dib B., and Panerai A. E. (1998) Interleukin-1 and nociception in the rat. J. Neurosci. Res. 53, 645-650.
4. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
5. Crofford L. J., Wilder R. L., Ristimäki A. P., Sano H., Remmers E. F., Epps H. R., and Hla T. (1994) Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester, and corticosteroids. J. Clin. Invest. 93, 1095-1101.
6. Cunningham E. T. and De Souza E. B. (1993) Interleukin-1 receptors in the brain and endocrine tissues. Immunol. Today 14, 171-176.
7. Dinarello C. A. (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652.
8. Eisenberg S. P., Evans R. J., Arend W. P. L., Verderber E., Brewer M. T., Hannum C. H., and Thompson R. C. (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343, 341-346.
9. Eskay R. L. and Eiden L. E. (1992) Interleukin-1α and tumor necrosis factor-α differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells. Endocrinology 130, 2252-2258.
10. Feng L., Sun W., Xia Y., Tang W. W., Chanmugam P., Soyoola E., Wilson C. B., and Hwang D. (1993) Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys. 307, 361-368.
11. Ferreira S. H., Lorenzetti B. B., Bristow A. F., and Poole S. (1988) Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334, 698-700.
12. Follenfant R. L., Nakamura-Craig M., Henderson B., and Higgs G. A. (1989) Inhibition by neuropeptides of interleukin-1β-induced, prostaglandin-independent hyperalgesia. Br. J. Pharmacol. 98, 41-43.
13. Freidin M. and Kessler J. A. (1991) Cytokine regulation of substance P expression in sympathetic neurons. Proc. Natl. Acad. Sci. USA 88, 3200-3203.
14. Fukuoka H., Kawatani M., Hisamitsu T., and Takeshige C. (1994) Cutaneous hyperalgesia induced by peripheral injection of interleukin-1β in the rat. Brain Res. 657, 133-140.
15. Futaki N., Arai I., Hamasaka Y., Takahashi S., Higuchi S., and Otomo S. (1993) Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J. Pharm. Pharmacol. 45, 753-755.
16. Garland A., Necheles J., White S. R., Neeley S. P., Leff A. R., Carson S. S., Alger L. E., McAllister K., and Solway J. (1997) Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons. Am. J. Physiol. 273, L1096-L1102.
17. Habib A., Créminon C., Frobert Y., Grassi J., Pradelles P., and Maclouf J. (1993) Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyterminal region of the cyclooxygenase-2. J. Biol. Chem. 268, 23448-23454.
18. Hart R. P., Shadiack A. M., and Jonakait G. M. (1991) Substance P gene expression is regulated by interleukin-1 in cultured sympathetic ganglia. J. Neurosci. Res. 29, 282-291.
19. Herschman H. R. (1996) Proslaglandin synthase 2. Biochim. Biophys. Acta 1299, 125-140.
20. Hingtgen C. M. and Vasko M. R. (1994) Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Res. 655, 51-60.
21. Hingtgen C. M., Waite K. J., and Vasko M. R. (1995) Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade. J. Neurosci. 15, 5411-5419.
22. Hirota N., Kuraishi Y., Hino Y., Sato Y., Satoh M., and Takagi H. (1985) Met-enkephalin and morphine but not dynorphin inhibit noxious stimuli-induced release of substance P from rabbit dorsal horn in situ. Neuropharmacology 24, 567-570.
23. Inoue A., Hashimoto T., Hide I., Nishio H., and Nakata Y. (1997) 5-Hydroxytryptamine-facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP. J. Neurochem. 68, 128-133.
24. Inoue A., Seto M., Sugita S., Hide I., Hirose T., Koga N., Kikuchi T., and Nakata Y. (1998) Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Mol. Brain Res. 55, 285-292.
25. Jonakait G. M. and Schotland S. (1990) Conditioned medium from activated splenocytes increases substance P in sympathetic ganglia. J. Neurosci. Res. 26, 24-30.
26. Jones D. A., Carlton D. P., McIntyre T. M., Zimmerman G. A., and Prescott S. M. (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268, 9049-9054.
27. Krause J. E., Chirgwin J. M., Carter M. S., Xu Z. S., and Hershey A. D. (1987) Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. USA 84, 881-885.
28. Lotz M., Vaughan J. H., and Carson D. A. (1988) Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241, 1218-1221.
29. Luber-Narod J., Kage R., and Leeman S. E. (1994) Substance P enhances the secretion of tumor necrosis factor-α from neuroglial cells stimulated with lipopolysaccharide. J. Immunol. 152, 819-824.
30. Lyons-Giordano B., Pratta M. A., Galbraith W., Davis G. L., and Arner E. C. (1993) Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2. Exp. Cell Res. 206, 58-62.
31. Malcangio M., Bowery N. G., Flower R. J., and Perretti M. (1996) Effect of interleukin-1β on the release of substance P from rat isolated spinal cord. Eur. J. Pharmacol. 299, 113-118.
32. Martin M., Neumann D., Hoff T., Resch K., DeWitt D. L., and Goppelt-Struebe M. (1994) Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int. 45, 150-158.
33. Masferrer J. L., Zweifel B. S., Manning P. T., Hauser S. D., Leahy K. M., Smith W. G., Isakson P. C., and Seibert K. (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228-3232.
34. McCarson K. E. and Krause J. E. (1995) The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration. Neuroscience 64, 729-739.
35. McMahan C. J., Slack J. L., Mosley B., Cosman D., Lupton S. D., Bunton L. L., Grubin C. E., Wignall J. M., Jenkins N. A., Brannan C. I., Copeland N. G., Huebner K., Croce C. M., Cannizzarro L. A., Benjamin D., Dower S. K., Spriggs M. K., and Sims J. E. (1991) A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10, 2821-2832.
36. Mousli M., Hugli T. E., Landry Y., and Bronner C. (1994) Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology 27, 1-11.
37. O'Banion M. K., Winn V. D., and Young D. A. (1992) cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA 89, 4888-4892.
38. O'Banion M. K., Miller J. C., Chang J. W., Kaplan M. D., and Coleman P. D. (1996) Interleukin-1β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J. Neurochem. 66, 2532-2540.
39. O'Byrne E. M., Blancuzzi V., Wilson D. E., Wong M., and Jeng A. Y. (1990) Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum. 33, 1023-1028.
40. Oida H., Namba T., Sugimoto Y., Ushikubi F., Ohishi H., Ichikawa A., and Narumiya S. (1995) In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br. J. Pharmacol. 97, 657-668.
41. Oka T., Oka K., Hosoi M., and Hori T. (1996) Inhibition of peripheral interleukin-1β-induced hyperalgesia by the intracerebroventricular administration of diclofenac and α-melanocyte-stimulating hormone. Brain Res. 736, 237-242.
42. Otsuka M., Konishi S., and Takahashi T. (1975) Hypothalamic substance P as a candidate for transmitter of primary afferent neurons. Fed. Proc. 34, 1922-1928.
43. Perretti M., Ahluwalia A., Flower R. J., and Manzini S. (1993) Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology 80, 73-77.
44. Randic M. and Miletic V. (1977) Effect of substance P in cat dorsal horn neurons activated by noxious stimuli. Brain Res. 128, 164-169.
45. Safieh-Garabedian B., Kanaan S. A., Haddad J. J., Jaoude P. A., Jabbur S. J., and Saadé N. E. (1997) Involvement of interleukin-1β, nerve growth factor and prostaglandin E2 in endotoxin-induced localized inflammatory hyperalgesia. Br. J. Pharmacol. 121, 1619-1626.
46. Shadiack A. M., Hart R. P., Carlson C. D., and Jonakait G. M. (1993) Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF). J. Neurosci. 13, 2601-2609.
47. Treede R, D., Meyer R. A., Raja S. N., and Campbell J. N. (1992) Peripheral and central mechanisms of cutaneous hyperalgesia. Prog. Neurobiol. 38, 397-421.
48. Vane J. R., Mitchell J. A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., and Willoughby D. A. (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91, 2046-2050.
49. Walsh D. T., Weg V. B., Williams T. J., and Nourshargh S. (1995) Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators. Br. J. Pharmacol. 114, 1343-1350.
50. Watkins L. R., Wiertelak E. P., Goehler L. E., Smity K. P., Martin D., and Maier S. F. (1994) Characterization of cytokine-induced hyperalgesia. Brain Res. 654, 15-26.
51. Watkins L. R., Maier S. F., and Goehler L. E. (1995) Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63, 289-302.
52. Yabuuchi K., Nishiyori A., Minami M., and Satoh M. (1996) Biphasic effects of intracerebroventricular interleukin-1β on mechanical nociception in the rat. Eur. J. Pharmacol. 300, 59-65.